Barely Significant
← all excerpts

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation.

Asian J Androl · 2017 · PMC5566856 · PMID 27506334

Europe PMCDOI
1
hedged sentence
0.0507
closest p · 1.0× alpha
0.0507
boldest claim

The sentences

a strong trendP = 0.0507so close (0.05 < p ≤ 0.1)
retrospectively analyzed the data from dose-escalation trial RTOG 9406 and found a strong trend toward improved disease-free survival associated with long-term ADT ( P = 0.0507) in patients with PSA >20 who received a cumulative RT dose above 73.8 Gy. 14 A review by Feng et al . of the results of DERT (75–79.2 Gy) in patients with high-risk prostate cancer 13 found that addition of ADT decreased the 5-year cumulative incidence of biochemical failure and distant metastases (35% vs 13%, P < 0.001).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.